Cadila Healthcare Ltd — Hydroxychloroquine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Hydroxychloroquine · $700.0K export value · DGFT Verified
Cadila Healthcare Ltd is the #4 Indian exporter of Hydroxychloroquine with $700.0K in export value and 14 verified shipments. Cadila Healthcare Ltd holds a 0.5% market share in Hydroxychloroquine exports across 4 countries.
Cadila Healthcare Ltd — Hydroxychloroquine Export Profile: Buyers & Destinations
Where Does Cadila Healthcare Ltd Export Hydroxychloroquine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.9M | 39 | 75.5% |
| THAILAND | $288.7K | 7 | 11.2% |
| VIETNAM | $250.0K | 5 | 9.7% |
| HONG KONG | $50.0K | 1 | 1.9% |
| SRI LANKA | $35.5K | 1 | 1.4% |
| BOLIVIA | $10.2K | 1 | 0.4% |
Cadila Healthcare Ltd exports Hydroxychloroquine to 6 countries. The largest destination is UNITED STATES accounting for 75.5% of Cadila Healthcare Ltd's Hydroxychloroquine shipments, followed by THAILAND (11.2%) and VIETNAM (9.7%). These destinations reflect Cadila Healthcare Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Hydroxychloroquine from Cadila Healthcare Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $1.8M | 36 |
| KASPA PHARMACEUTICAL THAILAND | THAILAND | $179.8K | 4 |
| HAPHARCOJ S CBRANCH | VIETNAM | $100.0K | 2 |
| NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $100.0K | 2 |
| HAPHARCO J S C BRANCH CHI MINH CITY | VIETNAM | $100.0K | 2 |
| KASPA PHARMACEUTICAL THAILAND CO LTD | THAILAND | $79.8K | 2 |
| HAPHARCO J S C BRANCH | VIETNAM | $50.0K | 1 |
| PRIORITY HEALTHCARE DISTRIBUTION DB | UNITED STATES | $50.0K | 1 |
| CHEMILL PHARMA LIMITED | HONG KONG | $50.0K | 1 |
| SUNSHINE HEALTHCARE LANKA LIMITED | SRI LANKA | $35.5K | 1 |
Cadila Healthcare Ltd supplies Hydroxychloroquine to 12 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by KASPA PHARMACEUTICAL THAILAND (THAILAND) and HAPHARCOJ S CBRANCH (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Hydroxychloroquine Export Value and How Much Does Cadila Healthcare Ltd Contribute?
India exported $26.0M worth of Hydroxychloroquine through 3,717 shipments from 163 suppliers to 86 countries, serving 271 buyers globally. Cadila Healthcare Ltd contributes $700.0K to this total, accounting for 0.5% of India's Hydroxychloroquine exports. Cadila Healthcare Ltd ships Hydroxychloroquine to 6 countries through 12 buyers.
What Is the Average Shipment Value for Cadila Healthcare Ltd's Hydroxychloroquine Exports?
Cadila Healthcare Ltd's average Hydroxychloroquine shipment value is $50.0K per consignment, based on 14 shipments totaling $700.0K. The largest destination is UNITED STATES (75.5% of Cadila Healthcare Ltd's Hydroxychloroquine exports).
How Does Cadila Healthcare Ltd Compare to Other Indian Hydroxychloroquine Exporters?
Cadila Healthcare Ltd ranks #4 among 163 Indian Hydroxychloroquine exporters with a 0.5% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($12.9M), IPCA LABORATORIES LIMITED ($7.3M), CADILA HEALTHCARE LIMITED ($2.0M). Cadila Healthcare Ltd processed 14 shipments to 4 destination countries.
What Hydroxychloroquine Formulations Does Cadila Healthcare Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA : HYDROXYCHLOROQUINE SULFATE TABL | $450.0K | 9 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 2 | $200.0K | 4 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X100 PER PACK] | $200.0K | 4 |
| HCQ HYDROXYCHLOROQUINE SULPHATE USP 200MG 10 X 10'S | $200.0K | 4 |
| ZYQUENIL HYDROXYCHLOROQUINE SULFATE TAB | $158.9K | 4 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG DIST. NDC - 68382-096-01 MANUFACTURING . NDC -65841-633-01 AS PER INVOICE. & P.LIST | $150.0K | 3 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG 1X100T | $150.0K | 3 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X500 PER PACK] | $150.0K | 3 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG | $100.0K | 2 |
| ZYQUENIL HYDROXYCHLOROQUINE SULFATE TABS USP 200MG 10 X 10T | $79.8K | 2 |
Cadila Healthcare Ltd exports 26 distinct Hydroxychloroquine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA : HYDROXYCHLOROQUINE SULFATE TABL with 9 shipments worth $450.0K.
Regulatory Requirements: Exporting Hydroxychloroquine to Key Markets
What Cadila Healthcare Ltd must comply with to export Hydroxychloroquine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cadila Healthcare Ltd Compare to Nearest Hydroxychloroquine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | CADILA HEALTHCARE LIMITED | $2.0M | 40 | 5 | $50.0K |
| 5 | INTAS PHARMACEUTICALS LIMITED | $1.1M | 21 | 3 | $50.0K |
| 4 | CADILA HEALTHCARE LTD ★ | $700.0K | 14 | 4 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $700.0K | 14 | 1 | $50.0K |
| 8 | CARITAS HEALTHCARE PRIVATE LIMITED | $523.4K | 11 | 1 | $47.6K |
Cadila Healthcare Ltd ranks #4 among 163 Indian Hydroxychloroquine exporters. Average shipment value of $50.0K compared to the market average of $159.2K. The closest competitors by value are CADILA HEALTHCARE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Hydroxychloroquine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 935 | 25.2% |
| SAHAR AIR | 756 | 20.3% |
| DELHI AIR CARGO ACC (INDEL4) | 610 | 16.4% |
| DELHI AIR | 305 | 8.2% |
| Bombay Air | 285 | 7.7% |
| MUNDRA SEA | 137 | 3.7% |
| Delhi Air | 116 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 76 | 2.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Hydroxychloroquine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Hydroxychloroquine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cadila Healthcare Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 54 individual customs records matching Cadila Healthcare Ltd exporting Hydroxychloroquine, covering 26 formulations to 6 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 86+ countries, 271+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Hydroxychloroquine Export Data from Cadila Healthcare Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Healthcare Ltd's Hydroxychloroquine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cadila Healthcare Ltd
Company Profile
0 products · $0 total trade · 0 categories
Hydroxychloroquine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cadila Healthcare Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Hydroxychloroquine. For current shipment-level data, contact TransData Nexus.